ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $52,200,000 | +92.3% | 630,282 | +54.0% | 0.34% | -1.2% |
| Q1 2021 | $27,143,000 | -67.0% | 409,341 | -61.8% | 0.34% | -61.1% |
| Q4 2020 | $82,164,000 | +4113.5% | 1,070,814 | +3383.7% | 0.88% | +2161.5% |
| Q4 2019 | $1,950,000 | +125.2% | 30,738 | 0.0% | 0.04% | +69.6% |
| Q3 2019 | $866,000 | -90.1% | 30,738 | -90.7% | 0.02% | -88.6% |
| Q2 2019 | $8,765,000 | +44.4% | 330,738 | 0.0% | 0.20% | +17.5% |
| Q1 2019 | $6,069,000 | +69.4% | 330,738 | +10.2% | 0.17% | +25.7% |
| Q4 2018 | $3,582,000 | -48.9% | 300,000 | -17.9% | 0.14% | -27.3% |
| Q3 2018 | $7,006,000 | +41.0% | 365,445 | 0.0% | 0.19% | +43.8% |
| Q2 2018 | $4,970,000 | +88.6% | 365,445 | 0.0% | 0.13% | +75.7% |
| Q1 2018 | $2,635,000 | +92.1% | 365,445 | -56.9% | 0.07% | +7.2% |
| Q2 2017 | $1,372,000 | -12.4% | 847,458 | 0.0% | 0.07% | -22.5% |
| Q1 2017 | $1,567,000 | +19.3% | 847,458 | 0.0% | 0.09% | -4.3% |
| Q4 2016 | $1,313,000 | -78.9% | 847,458 | 0.0% | 0.09% | -76.9% |
| Q3 2016 | $6,228,000 | – | 847,458 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,328 | $51,213,000 | 30.37% |
| JOHNSON & JOHNSON | 3,260,869 | $203,576,000 | 17.86% |
| ACT CAPITAL MANAGEMENT, LLC | 194,000 | $12,111,000 | 6.28% |
| Aquilo Capital Management, LLC | 527,926 | $32,958,000 | 5.99% |
| Evolutionary Tree Capital Management, LLC | 105,491 | $6,586,000 | 2.92% |
| ACUTA CAPITAL PARTNERS, LLC | 121,500 | $7,585,000 | 2.68% |
| L1 Capital Pty Ltd | 297,915 | $18,599,000 | 2.31% |
| Avidity Partners Management LP | 673,700 | $42,059,000 | 0.93% |
| Hood River Capital Management LLC | 338,734 | $21,147,000 | 0.65% |
| Tygh Capital Management, Inc. | 64,127 | $4,003,000 | 0.54% |